A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD

Clinical trial NCT00536016 · COMPLETED

Trial details

NCT number: NCT00536016
Sponsor: Jerini Ophthalmic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Macular Degeneration

Start date: 2007-09-01
Primary completion: 2008-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.